Rifapentine, Moxifloxacin, or DNA Vaccine Improves Treatment of Latent Tuberculosis in a Mouse Model

Rationale: Priorities for developing improved regimens for treatment of latent tuberculosis (TB) infection include (1) developing shorter and/or more intermittently administered regimens that are easier to supervise and (2) developing and evaluating regimens that are active against multidrug-resista...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nuermberger, Eric, Tyagi, Sandeep, Williams, Kathy N., Rosenthal, Ian, Bishai, William R., Grosset, Jacques H.
Formato: Artigo
Idioma:Inglês
Publicado em: American Thoracic Society 2005
Assuntos:
I. Tuberculosis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1853317/
https://ncbi.nlm.nih.gov/pubmed/16151038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.200507-1047OC
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados